During the past decade, South African Tuberculosis Vaccine Initiative (SATVI) CRS conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "South African Tuberculosis Vaccine Initiative (SATVI) CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 1 trials as a collaborator, "National Institute for Medical Research, Tanzania" with 1 trials as a collaborator, "Ospedale San Raffaele" with 1 trials as a collaborator and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "South African Tuberculosis Vaccine Initiative (SATVI) CRS" are "Tuberculosis" (2 trials), "HIV Infections" (1 trials), "Tuberculosis, MDR" (1 trials) and "Tuberculosis, Pulmonary" (1 trials). Many other conditions were trialed in "South African Tuberculosis Vaccine Initiative (SATVI) CRS" in a lesser frequency.

Most popular intervention types in "South African Tuberculosis Vaccine Initiative (SATVI) CRS" are "Drug" (3 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AERAS-404" (1 trials), "Bacillus Calmette-Guérin (BCG)" (1 trials), "Bedaquiline" (1 trials) and "Delamanid" (1 trials). Other intervention names were less common.

The vast majority of trials in "South African Tuberculosis Vaccine Initiative (SATVI) CRS" are 4 trials for "All" genders.

Currently, there are NaN active trials in "South African Tuberculosis Vaccine Initiative (SATVI) CRS". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in South African Tuberculosis Vaccine Initiative (SATVI) CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in South African Tuberculosis Vaccine Initiative (SATVI) CRS, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".